Search

Your search keyword '"Cossiga, Valentina"' showing total 174 results

Search Constraints

Start Over You searched for: Author "Cossiga, Valentina" Remove constraint Author: "Cossiga, Valentina"
174 results on '"Cossiga, Valentina"'

Search Results

1. Use of Telemedicine for Chronic Liver Disease at a Single Care Center During the COVID-19 Pandemic: Prospective Observational Study

2. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort

3. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

4. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

5. THU-378 Prediction of outcomes in patients with HCV compensated liver cirrhosis after SVR: results from 5-years of follow-up

6. SAT-007-YI Assessing sex differences in access to liver transplantation in Italy: a real-world nationwide study

7. LBP-038 Expanding knowledge regarding real-world treatment of patients with primary biliary cholangitis with obeticholic acid from the Italian RECAPITULATE cohort

8. THU-093 Biochemical response and liver stiffness variation over time predict liver-related events in patients with primary biliary cholangitis treated with Obeticholic acid

9. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort

11. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

13. Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients

16. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

19. Anti‐HDV reflex testing in HBsAg‐positive subjects: An efficacious strategy to identify HDV infection

20. Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort

21. Predicting de‐novoportal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort

22. Anti‐HDV reflex testing in HBsAg‐positive subjects: An efficacious strategy to identify HDV infection.

23. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

24. Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort

26. Visceral Obesity and Cytokeratin-18 Antigens as Early Biomarkers of Liver Damage

27. COVID-19 and Fatty Liver Disorders

30. Implementation of anti-HDV reflex testing among HBsAg-positive in a tertiary center in South Italy

31. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

34. Vascular liver diseases: A sex-oriented analysis of the literature

35. The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight

36. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

37. Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents

39. Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients

40. De-novo occurrence of portal vein thrombosis in patients with HCV-related cirrhosis after sustained virological response: medium to long term observations from the ongoing PITER cohort

41. Humoral response to 2-dose BNT162b2 mRNA vaccine for COVID-19 in liver transplant recipients

42. The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight.

45. Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study

47. Covid-19 in Liver Transplant Recipients: An Italian Case-Control Double-Centre Study.

48. Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD

49. Additional file 1 of Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort

50. Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma.

Catalog

Books, media, physical & digital resources